Sanisure completed the acquisition of Medical Elastomer Development from 3i Group-backed Q Holding.

Sanisure, a bioprocessing technology company, completed the acquisition of Medical Elastomer Development, a silicone extrusion company, from 3i Group-backed Q Holding, a global manufacturer of highly-engineered medical devices. Financial terms were not disclosed. "We are excited to have the MED Twinsburg Team joining Sanisure's growing family. We continue to invest in critical technologies and capabilities that drive innovation and supply security for our global customer base. State-of- the-art silicone extrusion capabilities are core to our portfolio of fluid management products and solutions, and enable us to provide both high quality silicone tubing and vertically integrated bioprocessing single-use solutions to our customers," Steven Chevillotte, Sanisure CEO.